TRAIL

DR4

DR5

DcR1

DcR2

ER

−

50.1 ± 21

12.8 ± 5.9

1.9 ± 0.4

1.9 ± 0.4

1.4 ± 0.2

+

48.1 ± 26.9

11.9 ± 5.8

1.9 ± 0.4

1.8 ± 0.5

1.5 ± 0.2

U (p)

1409 (0.336)

1949.5 (0.459)

1576.5 (0.967)

1308.5 (0.129)

1235.0 (0.054)

PR

−

52.2 ± 23.5

12.8 ± 5.8

1.9 ± 0.4

1.9 ± 0.4

1.4 ± 0.2

+

47 ± 26.1

11.9 ± 5.9

1.9 ± 0.4

1.8 ± 0.5

1.5 ± 0.2

U (p)

1422 (0.113)

1556 (0.318)

1676.0 (0.808)

1500 (0.241)

1442.5 (0.140)

Lymph node involvement

−

50.8 ± 25.9

12.4 ± 5.5

1.9 ± 0.4

1.8 ± 0.4

1.4 ± 0.2

+

47.1 ± 24.8

12 ± 6.1

1.9 ± 0.4

1.9 ± 0.5

1.5 ± 0.2

U (p)

1716 (0.380)

1825.5 (0.745)

1682.5 (0.295)

1813.5 (0.700)

1684.0 (0.299)

Histological grade

I

63 ± 41.2

10.4 ± 5.6

2 ± 0.6

1.7 ± 0.4

1.4 ± 0.3

II

51.1 ± 22

13 ± 5.6

1.9 ± 0.3

1.8 ± 0.5

1.4 ± 0.2

III

42.7 ± 23.4

11.6 ± 6.1

1.9 ± 0.5

1.9 ± 0.5

1.5 ± 0.2

H (p)

6.299 (0.044*)

3.009 (0.209)

0.874 (0.646)

0.957 (0.620)

2.218 (0.330)

Clinical stage

II

67.2 ± 34.9

12.4 ± 4.7

2 ± 0.6

1.8 ± 0.4

1.5 ± 0.2

III

51 ± 23.4

11.1 ± 5.6

1.9 ± 0.3

1.9 ± 0.4

1.4 ± 0.2